基于(关键地区、市场参与者、规模和份额)的脂质体药物输送市场 - 到 2031 年的预测

  • Report Code : TIPRE00010407
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 177
Buy Now

脂质体药物递送市场预计将从 2019 年的 35.9441 亿美元增至 2027 年的 69.9295 亿美元。预计 2020 年至 2027 年该市场将以 8.8% 的复合年增长率增长.

脂质体是一种新型药物递送系统(NDDS),是用于将药物或遗传物质递送到细胞中的双层囊泡结构。 NDDS 的目的是在治疗期间按照身体需要的速率输送药物。由于 COVID-19 患者数量不断增加,特别是在美国和欧洲国家,研究机构面临着加快研发活动的压力,以开发用于治疗的药物和疫苗。因此,脂质体药物输送市场的公司正在利用这个机会加强对纳米材料的研究,例如纳米球、脂质体和纳米颗粒等活性抗病毒剂。脂质体药物递送正在利用增加的体内和体外药物活性进行常规临床实践。

脂质体药物递送市场的利润丰厚的区域


市场洞察

慢性病患病率增加

在过去的几十年里,由于慢性病患病率的增加,脂质体药物输送系统的研发活动在世界范围内迅速增加。药物递送是施用药物化合物以在人体中达到治疗效果的过程。脂质体药物递送具有多种优点,例如改善的药代动力学和药效学、增强的治疗功效和降低的毒性,从而使这些递送系统成为患有各种慢性病的患者的理想选择。根据美国疾病控制与预防中心 (CDC) 2019 年的数据,美国近十分之六的人患有至少一种慢性病,十分之四的人患有两种或两种以上慢性病。

癌症是全世界人口死亡的主要原因之一。美国癌症协会 (ACS) 估计 2018 年诊断出约 1,735,350 例新癌症病例。靶向药物输送系统 (TDDS) 以受控方式在预先选择的生物位点输送药物。基于纳米技术的输送系统正在对癌症治疗产生重大影响,而聚合物在癌症治疗纳米颗粒载体的开发中发挥着关键作用。纳米治疗药物递送系统(NDDS)的一些主要技术优势包括延长半衰期、改善生物分布、增加药物的循环时间、药物的控制和持续释放、给药途径的多功能性、增加细胞间浓度毒品等等。纳米技术药物输送系统中使用的脂质体载体可能会得到快速采用,从而推动市场增长。

基于产品的市场洞察

h3>

脂质体给药市场根据产品分为脂质体阿霉素、脂质体紫杉醇、脂质体两性霉素B等。 2019年,脂质体阿霉素在副产品中占据最大份额,因为该药物在癌症治疗中表现出高效能。此外,脂质体阿霉素在毒性和靶向药物递送方面优于其传统对应物。该药物还在患有 HIV 相关卡波西肉瘤和多发性骨髓瘤的患者中表现出显着的康复效果。

全球脂质体药物输送市场(按产品) 2019年和2027年


基于技术的市场洞察

基于技术的脂质体药物递送市场细分为隐形脂质体技术、非聚乙二醇化脂质体技术、DepoFoam脂质体技术。隐形脂质体技术领域在 2019 年占据了最大的市场份额,并且在预测期内可能继续保持市场上最高的复合年增长率。

应用-基于市场洞察

基于技术,脂质体给药市场分为真菌疾病、癌症治疗、疼痛管理、病毒疫苗和光动力疗法。癌症治疗领域在 2019 年占据了最大的市场份额,并且在预测期内可能继续保持最高的复合年增长率。

战略见解< /h3>

合作伙伴关系、协议和收购是公司最常采用的策略,以扩大其全球足迹并满足不断增长的需求。市场参与者最常采用这些策略来扩大其地域影响力和产品组合。

例如,2019 年 4 月,Ipsen Pharma 完成了对剑桥 Merrimack Pharmaceuticals 的全球肿瘤资产的收购,该资产专注于 ONIVYDE (伊立替康脂质体注射液)用于治疗基于吉西他滨的治疗后疾病进展的胰腺转移性腺癌患者。

全球脂质体给药市场 –副产品

  • 脂质体阿霉素
  • 脂质体紫杉醇
  • 脂质体两性霉素B
  • 其他
< h3>全球脂质体药物递送市场 –按技术
  • 隐形脂质体技术
  • 非聚乙二醇化脂质体技术
  • DepoFoam脂质体技术
  • 溶血脂热敏脂质体(LTSL) ) 技术

全球脂质体药物输送市场 –按应用

  • 真菌病
  • 癌症治疗
  • 疼痛管理
  • 病毒疫苗
  • 光动力疗法

脂质体药物输送市场 –按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • < li>欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚< /li>
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿联酋
  • 南美洲和中美洲
    • 巴西
    • 阿根廷

  p>

公司简介

  • 武田药品工业株式会社
  • 诺华公司
  • 绿叶制药集团
  • 益普生制药< /li>
  • CELSION, Inc.
  • 吉利德科学公司
  • 安斯泰来制药公司
  • 强生公司Johnson Services, Inc.
  • Acrotech Biopharma, Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies - Liposome Drug Delivery Market

  1. Takeda Pharmaceutical Company Limited
  2. Novartis AG
  3. Luye Pharma Group
  4. Ipsen Pharma
  5. CELSION, Inc.
  6. Gilead Sciences, Inc.
  7. Astellas Pharma, Inc.
  8. Johnson & Johnson Services, Inc.
  9. Acrotech Biopharma, Inc.
  10. Pacira Biosciences, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports